Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:male population group'
(id=6950299 ; fe=en:male population group ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=14553 creation date=2017-06-25 touchdate=2025-08-27 17:20:58.000)
≈ 328 relations sortantes

  1. en:male population group -- r_associated #0: 27 / 1 -> néoplasme malin
    n1=en:male population group | n2=néoplasme malin | rel=r_associated | relid=0 | w=27
  2. en:male population group -- r_associated #0: 26 / 0.963 -> en:male
    n1=en:male population group | n2=en:male | rel=r_associated | relid=0 | w=26
  3. en:male population group -- r_associated #0: 25 / 0.926 -> en:abortion applicants
    n1=en:male population group | n2=en:abortion applicants | rel=r_associated | relid=0 | w=25
  4. en:male population group -- r_associated #0: 25 / 0.926 -> en:abstractor
    n1=en:male population group | n2=en:abstractor | rel=r_associated | relid=0 | w=25
  5. en:male population group -- r_associated #0: 25 / 0.926 -> en:adult
    n1=en:male population group | n2=en:adult | rel=r_associated | relid=0 | w=25
  6. en:male population group -- r_associated #0: 25 / 0.926 -> en:adult 18-65 years old
    n1=en:male population group | n2=en:adult 18-65 years old | rel=r_associated | relid=0 | w=25
  7. en:male population group -- r_associated #0: 25 / 0.926 -> en:adult children
    n1=en:male population group | n2=en:adult children | rel=r_associated | relid=0 | w=25
  8. en:male population group -- r_associated #0: 25 / 0.926 -> en:advocate
    n1=en:male population group | n2=en:advocate | rel=r_associated | relid=0 | w=25
  9. en:male population group -- r_associated #0: 25 / 0.926 -> en:age group
    n1=en:male population group | n2=en:age group | rel=r_associated | relid=0 | w=25
  10. en:male population group -- r_associated #0: 25 / 0.926 -> en:alcoholics
    n1=en:male population group | n2=en:alcoholics | rel=r_associated | relid=0 | w=25
  11. en:male population group -- r_associated #0: 25 / 0.926 -> en:animal owner
    n1=en:male population group | n2=en:animal owner | rel=r_associated | relid=0 | w=25
  12. en:male population group -- r_associated #0: 25 / 0.926 -> en:applicant
    n1=en:male population group | n2=en:applicant | rel=r_associated | relid=0 | w=25
  13. en:male population group -- r_associated #0: 25 / 0.926 -> en:athletes
    n1=en:male population group | n2=en:athletes | rel=r_associated | relid=0 | w=25
  14. en:male population group -- r_associated #0: 25 / 0.926 -> en:author
    n1=en:male population group | n2=en:author | rel=r_associated | relid=0 | w=25
  15. en:male population group -- r_associated #0: 25 / 0.926 -> en:blood, heart and circulation
    n1=en:male population group | n2=en:blood, heart and circulation | rel=r_associated | relid=0 | w=25
  16. en:male population group -- r_associated #0: 25 / 0.926 -> en:bones, joints and muscles
    n1=en:male population group | n2=en:bones, joints and muscles | rel=r_associated | relid=0 | w=25
  17. en:male population group -- r_associated #0: 25 / 0.926 -> en:brain and nerves
    n1=en:male population group | n2=en:brain and nerves | rel=r_associated | relid=0 | w=25
  18. en:male population group -- r_associated #0: 25 / 0.926 -> en:caregiver
    n1=en:male population group | n2=en:caregiver | rel=r_associated | relid=0 | w=25
  19. en:male population group -- r_associated #0: 25 / 0.926 -> en:castrated male
    n1=en:male population group | n2=en:castrated male | rel=r_associated | relid=0 | w=25
  20. en:male population group -- r_associated #0: 25 / 0.926 -> en:chairperson
    n1=en:male population group | n2=en:chairperson | rel=r_associated | relid=0 | w=25
  21. en:male population group -- r_associated #0: 25 / 0.926 -> en:child
    n1=en:male population group | n2=en:child | rel=r_associated | relid=0 | w=25
  22. en:male population group -- r_associated #0: 25 / 0.926 -> en:child of impaired parents
    n1=en:male population group | n2=en:child of impaired parents | rel=r_associated | relid=0 | w=25
  23. en:male population group -- r_associated #0: 25 / 0.926 -> en:child, abandoned
    n1=en:male population group | n2=en:child, abandoned | rel=r_associated | relid=0 | w=25
  24. en:male population group -- r_associated #0: 25 / 0.926 -> en:child, exceptional
    n1=en:male population group | n2=en:child, exceptional | rel=r_associated | relid=0 | w=25
  25. en:male population group -- r_associated #0: 25 / 0.926 -> en:cigarette smoker
    n1=en:male population group | n2=en:cigarette smoker | rel=r_associated | relid=0 | w=25
  26. en:male population group -- r_associated #0: 25 / 0.926 -> en:citizen
    n1=en:male population group | n2=en:citizen | rel=r_associated | relid=0 | w=25
  27. en:male population group -- r_associated #0: 25 / 0.926 -> en:classmate
    n1=en:male population group | n2=en:classmate | rel=r_associated | relid=0 | w=25
  28. en:male population group -- r_associated #0: 25 / 0.926 -> en:client
    n1=en:male population group | n2=en:client | rel=r_associated | relid=0 | w=25
  29. en:male population group -- r_associated #0: 25 / 0.926 -> en:company representative
    n1=en:male population group | n2=en:company representative | rel=r_associated | relid=0 | w=25
  30. en:male population group -- r_associated #0: 25 / 0.926 -> en:complementary and alternative therapies
    n1=en:male population group | n2=en:complementary and alternative therapies | rel=r_associated | relid=0 | w=25
  31. en:male population group -- r_associated #0: 25 / 0.926 -> en:consultant
    n1=en:male population group | n2=en:consultant | rel=r_associated | relid=0 | w=25
  32. en:male population group -- r_associated #0: 25 / 0.926 -> en:consumer
    n1=en:male population group | n2=en:consumer | rel=r_associated | relid=0 | w=25
  33. en:male population group -- r_associated #0: 25 / 0.926 -> en:contact person
    n1=en:male population group | n2=en:contact person | rel=r_associated | relid=0 | w=25
  34. en:male population group -- r_associated #0: 25 / 0.926 -> en:contraception
    n1=en:male population group | n2=en:contraception | rel=r_associated | relid=0 | w=25
  35. en:male population group -- r_associated #0: 25 / 0.926 -> en:coordinator
    n1=en:male population group | n2=en:coordinator | rel=r_associated | relid=0 | w=25
  36. en:male population group -- r_associated #0: 25 / 0.926 -> en:counselee
    n1=en:male population group | n2=en:counselee | rel=r_associated | relid=0 | w=25
  37. en:male population group -- r_associated #0: 25 / 0.926 -> en:crime victims
    n1=en:male population group | n2=en:crime victims | rel=r_associated | relid=0 | w=25
  38. en:male population group -- r_associated #0: 25 / 0.926 -> en:criminals
    n1=en:male population group | n2=en:criminals | rel=r_associated | relid=0 | w=25
  39. en:male population group -- r_associated #0: 25 / 0.926 -> en:curator
    n1=en:male population group | n2=en:curator | rel=r_associated | relid=0 | w=25
  40. en:male population group -- r_associated #0: 25 / 0.926 -> en:decedent
    n1=en:male population group | n2=en:decedent | rel=r_associated | relid=0 | w=25
  41. en:male population group -- r_associated #0: 25 / 0.926 -> en:delegate
    n1=en:male population group | n2=en:delegate | rel=r_associated | relid=0 | w=25
  42. en:male population group -- r_associated #0: 25 / 0.926 -> en:diabetes mellitus
    n1=en:male population group | n2=en:diabetes mellitus | rel=r_associated | relid=0 | w=25
  43. en:male population group -- r_associated #0: 25 / 0.926 -> en:diagnostic tests
    n1=en:male population group | n2=en:diagnostic tests | rel=r_associated | relid=0 | w=25
  44. en:male population group -- r_associated #0: 25 / 0.926 -> en:digestive system
    n1=en:male population group | n2=en:digestive system | rel=r_associated | relid=0 | w=25
  45. en:male population group -- r_associated #0: 25 / 0.926 -> en:disabled population
    n1=en:male population group | n2=en:disabled population | rel=r_associated | relid=0 | w=25
  46. en:male population group -- r_associated #0: 25 / 0.926 -> en:disaster victims
    n1=en:male population group | n2=en:disaster victims | rel=r_associated | relid=0 | w=25
  47. en:male population group -- r_associated #0: 25 / 0.926 -> en:disasters
    n1=en:male population group | n2=en:disasters | rel=r_associated | relid=0 | w=25
  48. en:male population group -- r_associated #0: 25 / 0.926 -> en:distributor
    n1=en:male population group | n2=en:distributor | rel=r_associated | relid=0 | w=25
  49. en:male population group -- r_associated #0: 25 / 0.926 -> en:drug user
    n1=en:male population group | n2=en:drug user | rel=r_associated | relid=0 | w=25
  50. en:male population group -- r_associated #0: 25 / 0.926 -> en:ear, nose and throat
    n1=en:male population group | n2=en:ear, nose and throat | rel=r_associated | relid=0 | w=25
  51. en:male population group -- r_associated #0: 25 / 0.926 -> en:educational aspects
    n1=en:male population group | n2=en:educational aspects | rel=r_associated | relid=0 | w=25
  52. en:male population group -- r_associated #0: 25 / 0.926 -> en:elderly
    n1=en:male population group | n2=en:elderly | rel=r_associated | relid=0 | w=25
  53. en:male population group -- r_associated #0: 25 / 0.926 -> en:elderly adult [disease/finding]
    n1=en:male population group | n2=en:elderly adult [disease/finding] | rel=r_associated | relid=0 | w=25
  54. en:male population group -- r_associated #0: 25 / 0.926 -> en:emancipated minor
    n1=en:male population group | n2=en:emancipated minor | rel=r_associated | relid=0 | w=25
  55. en:male population group -- r_associated #0: 25 / 0.926 -> en:emigrants and immigrants
    n1=en:male population group | n2=en:emigrants and immigrants | rel=r_associated | relid=0 | w=25
  56. en:male population group -- r_associated #0: 25 / 0.926 -> en:endocrine system
    n1=en:male population group | n2=en:endocrine system | rel=r_associated | relid=0 | w=25
  57. en:male population group -- r_associated #0: 25 / 0.926 -> en:eyes and vision
    n1=en:male population group | n2=en:eyes and vision | rel=r_associated | relid=0 | w=25
  58. en:male population group -- r_associated #0: 25 / 0.926 -> en:family member
    n1=en:male population group | n2=en:family member | rel=r_associated | relid=0 | w=25
  59. en:male population group -- r_associated #0: 25 / 0.926 -> en:famous persons
    n1=en:male population group | n2=en:famous persons | rel=r_associated | relid=0 | w=25
  60. en:male population group -- r_associated #0: 25 / 0.926 -> en:female reproductive system
    n1=en:male population group | n2=en:female reproductive system | rel=r_associated | relid=0 | w=25
  61. en:male population group -- r_associated #0: 25 / 0.926 -> en:fitness
    n1=en:male population group | n2=en:fitness | rel=r_associated | relid=0 | w=25
  62. en:male population group -- r_associated #0: 25 / 0.926 -> en:food and nutrition
    n1=en:male population group | n2=en:food and nutrition | rel=r_associated | relid=0 | w=25
  63. en:male population group -- r_associated #0: 25 / 0.926 -> en:friend
    n1=en:male population group | n2=en:friend | rel=r_associated | relid=0 | w=25
  64. en:male population group -- r_associated #0: 25 / 0.926 -> en:gay, lesbian, bisexual and transgender health
    n1=en:male population group | n2=en:gay, lesbian, bisexual and transgender health | rel=r_associated | relid=0 | w=25
  65. en:male population group -- r_associated #0: 25 / 0.926 -> en:general categories of people
    n1=en:male population group | n2=en:general categories of people | rel=r_associated | relid=0 | w=25
  66. en:male population group -- r_associated #0: 25 / 0.926 -> en:genetic carrier
    n1=en:male population group | n2=en:genetic carrier | rel=r_associated | relid=0 | w=25
  67. en:male population group -- r_associated #0: 25 / 0.926 -> en:genetics/birth defects
    n1=en:male population group | n2=en:genetics/birth defects | rel=r_associated | relid=0 | w=25
  68. en:male population group -- r_associated #0: 25 / 0.926 -> en:grandparent
    n1=en:male population group | n2=en:grandparent | rel=r_associated | relid=0 | w=25
  69. en:male population group -- r_associated #0: 25 / 0.926 -> en:guarantor
    n1=en:male population group | n2=en:guarantor | rel=r_associated | relid=0 | w=25
  70. en:male population group -- r_associated #0: 25 / 0.926 -> en:guardian
    n1=en:male population group | n2=en:guardian | rel=r_associated | relid=0 | w=25
  71. en:male population group -- r_associated #0: 25 / 0.926 -> en:health system
    n1=en:male population group | n2=en:health system | rel=r_associated | relid=0 | w=25
  72. en:male population group -- r_associated #0: 25 / 0.926 -> en:health, sexual
    n1=en:male population group | n2=en:health, sexual | rel=r_associated | relid=0 | w=25
  73. en:male population group -- r_associated #0: 25 / 0.926 -> en:healthcare issues for children and teenagers
    n1=en:male population group | n2=en:healthcare issues for children and teenagers | rel=r_associated | relid=0 | w=25
  74. en:male population group -- r_associated #0: 25 / 0.926 -> en:holder
    n1=en:male population group | n2=en:holder | rel=r_associated | relid=0 | w=25
  75. en:male population group -- r_associated #0: 25 / 0.926 -> en:homebound persons
    n1=en:male population group | n2=en:homebound persons | rel=r_associated | relid=0 | w=25
  76. en:male population group -- r_associated #0: 25 / 0.926 -> en:homeless persons
    n1=en:male population group | n2=en:homeless persons | rel=r_associated | relid=0 | w=25
  77. en:male population group -- r_associated #0: 25 / 0.926 -> en:housemate
    n1=en:male population group | n2=en:housemate | rel=r_associated | relid=0 | w=25
  78. en:male population group -- r_associated #0: 25 / 0.926 -> en:human middle age (35-64)
    n1=en:male population group | n2=en:human middle age (35-64) | rel=r_associated | relid=0 | w=25
  79. en:male population group -- r_associated #0: 25 / 0.926 -> en:human old age (65+)
    n1=en:male population group | n2=en:human old age (65+) | rel=r_associated | relid=0 | w=25
  80. en:male population group -- r_associated #0: 25 / 0.926 -> en:human study subject
    n1=en:male population group | n2=en:human study subject | rel=r_associated | relid=0 | w=25
  81. en:male population group -- r_associated #0: 25 / 0.926 -> en:immigrant
    n1=en:male population group | n2=en:immigrant | rel=r_associated | relid=0 | w=25
  82. en:male population group -- r_associated #0: 25 / 0.926 -> en:immune system
    n1=en:male population group | n2=en:immune system | rel=r_associated | relid=0 | w=25
  83. en:male population group -- r_associated #0: 25 / 0.926 -> en:impotence
    n1=en:male population group | n2=en:impotence | rel=r_associated | relid=0 | w=25
  84. en:male population group -- r_associated #0: 25 / 0.926 -> en:index case
    n1=en:male population group | n2=en:index case | rel=r_associated | relid=0 | w=25
  85. en:male population group -- r_associated #0: 25 / 0.926 -> en:infection
    n1=en:male population group | n2=en:infection | rel=r_associated | relid=0 | w=25
  86. en:male population group -- r_associated #0: 25 / 0.926 -> en:infertility
    n1=en:male population group | n2=en:infertility | rel=r_associated | relid=0 | w=25
  87. en:male population group -- r_associated #0: 25 / 0.926 -> en:interviewee
    n1=en:male population group | n2=en:interviewee | rel=r_associated | relid=0 | w=25
  88. en:male population group -- r_associated #0: 25 / 0.926 -> en:invoker
    n1=en:male population group | n2=en:invoker | rel=r_associated | relid=0 | w=25
  89. en:male population group -- r_associated #0: 25 / 0.926 -> en:jehovah's witness, follower of religion
    n1=en:male population group | n2=en:jehovah's witness, follower of religion | rel=r_associated | relid=0 | w=25
  90. en:male population group -- r_associated #0: 25 / 0.926 -> en:kidneys and urinary system
    n1=en:male population group | n2=en:kidneys and urinary system | rel=r_associated | relid=0 | w=25
  91. en:male population group -- r_associated #0: 25 / 0.926 -> en:klinefelter syndrome
    n1=en:male population group | n2=en:klinefelter syndrome | rel=r_associated | relid=0 | w=25
  92. en:male population group -- r_associated #0: 25 / 0.926 -> en:laryngectomee
    n1=en:male population group | n2=en:laryngectomee | rel=r_associated | relid=0 | w=25
  93. en:male population group -- r_associated #0: 25 / 0.926 -> en:legal adult
    n1=en:male population group | n2=en:legal adult | rel=r_associated | relid=0 | w=25
  94. en:male population group -- r_associated #0: 25 / 0.926 -> en:long-term facility resident
    n1=en:male population group | n2=en:long-term facility resident | rel=r_associated | relid=0 | w=25
  95. en:male population group -- r_associated #0: 25 / 0.926 -> en:lungs and breathing
    n1=en:male population group | n2=en:lungs and breathing | rel=r_associated | relid=0 | w=25
  96. en:male population group -- r_associated #0: 25 / 0.926 -> en:male breast carcinoma
    n1=en:male population group | n2=en:male breast carcinoma | rel=r_associated | relid=0 | w=25
  97. en:male population group -- r_associated #0: 25 / 0.926 -> en:male circumcision
    n1=en:male population group | n2=en:male circumcision | rel=r_associated | relid=0 | w=25
  98. en:male population group -- r_associated #0: 25 / 0.926 -> en:male gender
    n1=en:male population group | n2=en:male gender | rel=r_associated | relid=0 | w=25
  99. en:male population group -- r_associated #0: 25 / 0.926 -> en:male infertility
    n1=en:male population group | n2=en:male infertility | rel=r_associated | relid=0 | w=25
  100. en:male population group -- r_associated #0: 25 / 0.926 -> en:male phenotype
    n1=en:male population group | n2=en:male phenotype | rel=r_associated | relid=0 | w=25
  101. en:male population group -- r_associated #0: 25 / 0.926 -> en:male reproductive system
    n1=en:male population group | n2=en:male reproductive system | rel=r_associated | relid=0 | w=25
  102. en:male population group -- r_associated #0: 25 / 0.926 -> en:male, self-report
    n1=en:male population group | n2=en:male, self-report | rel=r_associated | relid=0 | w=25
  103. en:male population group -- r_associated #0: 25 / 0.926 -> en:malignant neoplasm
    n1=en:male population group | n2=en:malignant neoplasm | rel=r_associated | relid=0 | w=25
  104. en:male population group -- r_associated #0: 25 / 0.926 -> en:malignant testicular neoplasm
    n1=en:male population group | n2=en:malignant testicular neoplasm | rel=r_associated | relid=0 | w=25
  105. en:male population group -- r_associated #0: 25 / 0.926 -> en:man
    n1=en:male population group | n2=en:man | rel=r_associated | relid=0 | w=25
  106. en:male population group -- r_associated #0: 25 / 0.926 -> en:mature adult
    n1=en:male population group | n2=en:mature adult | rel=r_associated | relid=0 | w=25
  107. en:male population group -- r_associated #0: 25 / 0.926 -> en:medically uninsured
    n1=en:male population group | n2=en:medically uninsured | rel=r_associated | relid=0 | w=25
  108. en:male population group -- r_associated #0: 25 / 0.926 -> en:medlineplus health topics
    n1=en:male population group | n2=en:medlineplus health topics | rel=r_associated | relid=0 | w=25
  109. en:male population group -- r_associated #0: 25 / 0.926 -> en:member
    n1=en:male population group | n2=en:member | rel=r_associated | relid=0 | w=25
  110. en:male population group -- r_associated #0: 25 / 0.926 -> en:men
    n1=en:male population group | n2=en:men | rel=r_associated | relid=0 | w=25
  111. en:male population group -- r_associated #0: 25 / 0.926 -> en:men's health (attribute)
    n1=en:male population group | n2=en:men's health (attribute) | rel=r_associated | relid=0 | w=25
  112. en:male population group -- r_associated #0: 25 / 0.926 -> en:menfolk
    n1=en:male population group | n2=en:menfolk | rel=r_associated | relid=0 | w=25
  113. en:male population group -- r_associated #0: 25 / 0.926 -> en:mental health.behavior
    n1=en:male population group | n2=en:mental health.behavior | rel=r_associated | relid=0 | w=25
  114. en:male population group -- r_associated #0: 25 / 0.926 -> en:mentors
    n1=en:male population group | n2=en:mentors | rel=r_associated | relid=0 | w=25
  115. en:male population group -- r_associated #0: 25 / 0.926 -> en:metabolic problems
    n1=en:male population group | n2=en:metabolic problems | rel=r_associated | relid=0 | w=25
  116. en:male population group -- r_associated #0: 25 / 0.926 -> en:middle adult
    n1=en:male population group | n2=en:middle adult | rel=r_associated | relid=0 | w=25
  117. en:male population group -- r_associated #0: 25 / 0.926 -> en:middle aged adult [disease/finding]
    n1=en:male population group | n2=en:middle aged adult [disease/finding] | rel=r_associated | relid=0 | w=25
  118. en:male population group -- r_associated #0: 25 / 0.926 -> en:migrant farm worker
    n1=en:male population group | n2=en:migrant farm worker | rel=r_associated | relid=0 | w=25
  119. en:male population group -- r_associated #0: 25 / 0.926 -> en:migratory worker
    n1=en:male population group | n2=en:migratory worker | rel=r_associated | relid=0 | w=25
  120. en:male population group -- r_associated #0: 25 / 0.926 -> en:minor (person)
    n1=en:male population group | n2=en:minor (person) | rel=r_associated | relid=0 | w=25
  121. en:male population group -- r_associated #0: 25 / 0.926 -> en:missionaries
    n1=en:male population group | n2=en:missionaries | rel=r_associated | relid=0 | w=25
  122. en:male population group -- r_associated #0: 25 / 0.926 -> en:mouth and teeth
    n1=en:male population group | n2=en:mouth and teeth | rel=r_associated | relid=0 | w=25
  123. en:male population group -- r_associated #0: 25 / 0.926 -> en:multiple birth offspring
    n1=en:male population group | n2=en:multiple birth offspring | rel=r_associated | relid=0 | w=25
  124. en:male population group -- r_associated #0: 25 / 0.926 -> en:mutation carrier
    n1=en:male population group | n2=en:mutation carrier | rel=r_associated | relid=0 | w=25
  125. en:male population group -- r_associated #0: 25 / 0.926 -> en:non-citizen national
    n1=en:male population group | n2=en:non-citizen national | rel=r_associated | relid=0 | w=25
  126. en:male population group -- r_associated #0: 25 / 0.926 -> en:non-us citizen
    n1=en:male population group | n2=en:non-us citizen | rel=r_associated | relid=0 | w=25
  127. en:male population group -- r_associated #0: 25 / 0.926 -> en:noncarrier
    n1=en:male population group | n2=en:noncarrier | rel=r_associated | relid=0 | w=25
  128. en:male population group -- r_associated #0: 25 / 0.926 -> en:nurses, male
    n1=en:male population group | n2=en:nurses, male | rel=r_associated | relid=0 | w=25
  129. en:male population group -- r_associated #0: 25 / 0.926 -> en:obese adult
    n1=en:male population group | n2=en:obese adult | rel=r_associated | relid=0 | w=25
  130. en:male population group -- r_associated #0: 25 / 0.926 -> en:occupational group
    n1=en:male population group | n2=en:occupational group | rel=r_associated | relid=0 | w=25
  131. en:male population group -- r_associated #0: 25 / 0.926 -> en:operator
    n1=en:male population group | n2=en:operator | rel=r_associated | relid=0 | w=25
  132. en:male population group -- r_associated #0: 25 / 0.926 -> en:orphan child
    n1=en:male population group | n2=en:orphan child | rel=r_associated | relid=0 | w=25
  133. en:male population group -- r_associated #0: 25 / 0.926 -> en:owner
    n1=en:male population group | n2=en:owner | rel=r_associated | relid=0 | w=25
  134. en:male population group -- r_associated #0: 25 / 0.926 -> en:parent
    n1=en:male population group | n2=en:parent | rel=r_associated | relid=0 | w=25
  135. en:male population group -- r_associated #0: 25 / 0.926 -> en:participant
    n1=en:male population group | n2=en:participant | rel=r_associated | relid=0 | w=25
  136. en:male population group -- r_associated #0: 25 / 0.926 -> en:partner
    n1=en:male population group | n2=en:partner | rel=r_associated | relid=0 | w=25
  137. en:male population group -- r_associated #0: 25 / 0.926 -> en:patient
    n1=en:male population group | n2=en:patient | rel=r_associated | relid=0 | w=25
  138. en:male population group -- r_associated #0: 25 / 0.926 -> en:patient family member or friend
    n1=en:male population group | n2=en:patient family member or friend | rel=r_associated | relid=0 | w=25
  139. en:male population group -- r_associated #0: 25 / 0.926 -> en:pedestrians
    n1=en:male population group | n2=en:pedestrians | rel=r_associated | relid=0 | w=25
  140. en:male population group -- r_associated #0: 25 / 0.926 -> en:peer
    n1=en:male population group | n2=en:peer | rel=r_associated | relid=0 | w=25
  141. en:male population group -- r_associated #0: 25 / 0.926 -> en:penile disorder
    n1=en:male population group | n2=en:penile disorder | rel=r_associated | relid=0 | w=25
  142. en:male population group -- r_associated #0: 25 / 0.926 -> en:people
    n1=en:male population group | n2=en:people | rel=r_associated | relid=0 | w=25
  143. en:male population group -- r_associated #0: 25 / 0.926 -> en:person
    n1=en:male population group | n2=en:person | rel=r_associated | relid=0 | w=25
  144. en:male population group -- r_associated #0: 25 / 0.926 -> en:person categorized by affiliation with belief system
    n1=en:male population group | n2=en:person categorized by affiliation with belief system | rel=r_associated | relid=0 | w=25
  145. en:male population group -- r_associated #0: 25 / 0.926 -> en:person categorized by age
    n1=en:male population group | n2=en:person categorized by age | rel=r_associated | relid=0 | w=25
  146. en:male population group -- r_associated #0: 25 / 0.926 -> en:person exposed to disease
    n1=en:male population group | n2=en:person exposed to disease | rel=r_associated | relid=0 | w=25
  147. en:male population group -- r_associated #0: 25 / 0.926 -> en:person in the community environment
    n1=en:male population group | n2=en:person in the community environment | rel=r_associated | relid=0 | w=25
  148. en:male population group -- r_associated #0: 25 / 0.926 -> en:person in the healthcare environment
    n1=en:male population group | n2=en:person in the healthcare environment | rel=r_associated | relid=0 | w=25
  149. en:male population group -- r_associated #0: 25 / 0.926 -> en:person observer
    n1=en:male population group | n2=en:person observer | rel=r_associated | relid=0 | w=25
  150. en:male population group -- r_associated #0: 25 / 0.926 -> en:person with characteristic related to subject of record
    n1=en:male population group | n2=en:person with characteristic related to subject of record | rel=r_associated | relid=0 | w=25
  151. en:male population group -- r_associated #0: 25 / 0.926 -> en:personal health issues
    n1=en:male population group | n2=en:personal health issues | rel=r_associated | relid=0 | w=25
  152. en:male population group -- r_associated #0: 25 / 0.926 -> en:pharmacotherapy
    n1=en:male population group | n2=en:pharmacotherapy | rel=r_associated | relid=0 | w=25
  153. en:male population group -- r_associated #0: 25 / 0.926 -> en:poisoning, toxicology, environmental health
    n1=en:male population group | n2=en:poisoning, toxicology, environmental health | rel=r_associated | relid=0 | w=25
  154. en:male population group -- r_associated #0: 25 / 0.926 -> en:population group
    n1=en:male population group | n2=en:population group | rel=r_associated | relid=0 | w=25
  155. en:male population group -- r_associated #0: 25 / 0.926 -> en:population member
    n1=en:male population group | n2=en:population member | rel=r_associated | relid=0 | w=25
  156. en:male population group -- r_associated #0: 25 / 0.926 -> en:preconception care
    n1=en:male population group | n2=en:preconception care | rel=r_associated | relid=0 | w=25
  157. en:male population group -- r_associated #0: 25 / 0.926 -> en:pregnancy and reproduction
    n1=en:male population group | n2=en:pregnancy and reproduction | rel=r_associated | relid=0 | w=25
  158. en:male population group -- r_associated #0: 25 / 0.926 -> en:prisoners
    n1=en:male population group | n2=en:prisoners | rel=r_associated | relid=0 | w=25
  159. en:male population group -- r_associated #0: 25 / 0.926 -> en:producer
    n1=en:male population group | n2=en:producer | rel=r_associated | relid=0 | w=25
  160. en:male population group -- r_associated #0: 25 / 0.926 -> en:prostate carcinoma
    n1=en:male population group | n2=en:prostate carcinoma | rel=r_associated | relid=0 | w=25
  161. en:male population group -- r_associated #0: 25 / 0.926 -> en:prostate disorder
    n1=en:male population group | n2=en:prostate disorder | rel=r_associated | relid=0 | w=25
  162. en:male population group -- r_associated #0: 25 / 0.926 -> en:psychology qualifier
    n1=en:male population group | n2=en:psychology qualifier | rel=r_associated | relid=0 | w=25
  163. en:male population group -- r_associated #0: 25 / 0.926 -> en:qualified person
    n1=en:male population group | n2=en:qualified person | rel=r_associated | relid=0 | w=25
  164. en:male population group -- r_associated #0: 25 / 0.926 -> en:reader
    n1=en:male population group | n2=en:reader | rel=r_associated | relid=0 | w=25
  165. en:male population group -- r_associated #0: 25 / 0.926 -> en:recipient
    n1=en:male population group | n2=en:recipient | rel=r_associated | relid=0 | w=25
  166. en:male population group -- r_associated #0: 25 / 0.926 -> en:refugee
    n1=en:male population group | n2=en:refugee | rel=r_associated | relid=0 | w=25
  167. en:male population group -- r_associated #0: 25 / 0.926 -> en:reproductive hazards
    n1=en:male population group | n2=en:reproductive hazards | rel=r_associated | relid=0 | w=25
  168. en:male population group -- r_associated #0: 25 / 0.926 -> en:research subject
    n1=en:male population group | n2=en:research subject | rel=r_associated | relid=0 | w=25
  169. en:male population group -- r_associated #0: 25 / 0.926 -> en:resident
    n1=en:male population group | n2=en:resident | rel=r_associated | relid=0 | w=25
  170. en:male population group -- r_associated #0: 25 / 0.926 -> en:responsible person
    n1=en:male population group | n2=en:responsible person | rel=r_associated | relid=0 | w=25
  171. en:male population group -- r_associated #0: 25 / 0.926 -> en:reviewer
    n1=en:male population group | n2=en:reviewer | rel=r_associated | relid=0 | w=25
  172. en:male population group -- r_associated #0: 25 / 0.926 -> en:safety issues
    n1=en:male population group | n2=en:safety issues | rel=r_associated | relid=0 | w=25
  173. en:male population group -- r_associated #0: 25 / 0.926 -> en:schoolmate
    n1=en:male population group | n2=en:schoolmate | rel=r_associated | relid=0 | w=25
  174. en:male population group -- r_associated #0: 25 / 0.926 -> en:screening for prostate cancer
    n1=en:male population group | n2=en:screening for prostate cancer | rel=r_associated | relid=0 | w=25
  175. en:male population group -- r_associated #0: 25 / 0.926 -> en:sender
    n1=en:male population group | n2=en:sender | rel=r_associated | relid=0 | w=25
  176. en:male population group -- r_associated #0: 25 / 0.926 -> en:seniors' health
    n1=en:male population group | n2=en:seniors' health | rel=r_associated | relid=0 | w=25
  177. en:male population group -- r_associated #0: 25 / 0.926 -> en:sex workers
    n1=en:male population group | n2=en:sex workers | rel=r_associated | relid=0 | w=25
  178. en:male population group -- r_associated #0: 25 / 0.926 -> en:sexual health issues
    n1=en:male population group | n2=en:sexual health issues | rel=r_associated | relid=0 | w=25
  179. en:male population group -- r_associated #0: 25 / 0.926 -> en:sexual partner
    n1=en:male population group | n2=en:sexual partner | rel=r_associated | relid=0 | w=25
  180. en:male population group -- r_associated #0: 25 / 0.926 -> en:sexual problems in men
    n1=en:male population group | n2=en:sexual problems in men | rel=r_associated | relid=0 | w=25
  181. en:male population group -- r_associated #0: 25 / 0.926 -> en:sexually transmitted disorder
    n1=en:male population group | n2=en:sexually transmitted disorder | rel=r_associated | relid=0 | w=25
  182. en:male population group -- r_associated #0: 25 / 0.926 -> en:sibling
    n1=en:male population group | n2=en:sibling | rel=r_associated | relid=0 | w=25
  183. en:male population group -- r_associated #0: 25 / 0.926 -> en:significant other
    n1=en:male population group | n2=en:significant other | rel=r_associated | relid=0 | w=25
  184. en:male population group -- r_associated #0: 25 / 0.926 -> en:skin, hair and nails
    n1=en:male population group | n2=en:skin, hair and nails | rel=r_associated | relid=0 | w=25
  185. en:male population group -- r_associated #0: 25 / 0.926 -> en:slaves
    n1=en:male population group | n2=en:slaves | rel=r_associated | relid=0 | w=25
  186. en:male population group -- r_associated #0: 25 / 0.926 -> en:social/family issues
    n1=en:male population group | n2=en:social/family issues | rel=r_associated | relid=0 | w=25
  187. en:male population group -- r_associated #0: 25 / 0.926 -> en:sponsor
    n1=en:male population group | n2=en:sponsor | rel=r_associated | relid=0 | w=25
  188. en:male population group -- r_associated #0: 25 / 0.926 -> en:spouse
    n1=en:male population group | n2=en:spouse | rel=r_associated | relid=0 | w=25
  189. en:male population group -- r_associated #0: 25 / 0.926 -> en:stronger sex
    n1=en:male population group | n2=en:stronger sex | rel=r_associated | relid=0 | w=25
  190. en:male population group -- r_associated #0: 25 / 0.926 -> en:student
    n1=en:male population group | n2=en:student | rel=r_associated | relid=0 | w=25
  191. en:male population group -- r_associated #0: 25 / 0.926 -> en:subject of record or other provider of history
    n1=en:male population group | n2=en:subject of record or other provider of history | rel=r_associated | relid=0 | w=25
  192. en:male population group -- r_associated #0: 25 / 0.926 -> en:substance abuse
    n1=en:male population group | n2=en:substance abuse | rel=r_associated | relid=0 | w=25
  193. en:male population group -- r_associated #0: 25 / 0.926 -> en:surgery and rehabilitation
    n1=en:male population group | n2=en:surgery and rehabilitation | rel=r_associated | relid=0 | w=25
  194. en:male population group -- r_associated #0: 25 / 0.926 -> en:survivor
    n1=en:male population group | n2=en:survivor | rel=r_associated | relid=0 | w=25
  195. en:male population group -- r_associated #0: 25 / 0.926 -> en:symptom
    n1=en:male population group | n2=en:symptom | rel=r_associated | relid=0 | w=25
  196. en:male population group -- r_associated #0: 25 / 0.926 -> en:teenager
    n1=en:male population group | n2=en:teenager | rel=r_associated | relid=0 | w=25
  197. en:male population group -- r_associated #0: 25 / 0.926 -> en:terminally ill
    n1=en:male population group | n2=en:terminally ill | rel=r_associated | relid=0 | w=25
  198. en:male population group -- r_associated #0: 25 / 0.926 -> en:testicular disorder
    n1=en:male population group | n2=en:testicular disorder | rel=r_associated | relid=0 | w=25
  199. en:male population group -- r_associated #0: 25 / 0.926 -> en:the stronger sex
    n1=en:male population group | n2=en:the stronger sex | rel=r_associated | relid=0 | w=25
  200. en:male population group -- r_associated #0: 25 / 0.926 -> en:tissue donor
    n1=en:male population group | n2=en:tissue donor | rel=r_associated | relid=0 | w=25
  201. en:male population group -- r_associated #0: 25 / 0.926 -> en:transgendered persons
    n1=en:male population group | n2=en:transgendered persons | rel=r_associated | relid=0 | w=25
  202. en:male population group -- r_associated #0: 25 / 0.926 -> en:transients and migrants
    n1=en:male population group | n2=en:transients and migrants | rel=r_associated | relid=0 | w=25
  203. en:male population group -- r_associated #0: 25 / 0.926 -> en:transplant recipients
    n1=en:male population group | n2=en:transplant recipients | rel=r_associated | relid=0 | w=25
  204. en:male population group -- r_associated #0: 25 / 0.926 -> en:transplantation and donation
    n1=en:male population group | n2=en:transplantation and donation | rel=r_associated | relid=0 | w=25
  205. en:male population group -- r_associated #0: 25 / 0.926 -> en:unmarried person
    n1=en:male population group | n2=en:unmarried person | rel=r_associated | relid=0 | w=25
  206. en:male population group -- r_associated #0: 25 / 0.926 -> en:unwanted children
    n1=en:male population group | n2=en:unwanted children | rel=r_associated | relid=0 | w=25
  207. en:male population group -- r_associated #0: 25 / 0.926 -> en:user
    n1=en:male population group | n2=en:user | rel=r_associated | relid=0 | w=25
  208. en:male population group -- r_associated #0: 25 / 0.926 -> en:vasectomy
    n1=en:male population group | n2=en:vasectomy | rel=r_associated | relid=0 | w=25
  209. en:male population group -- r_associated #0: 25 / 0.926 -> en:vegetarian
    n1=en:male population group | n2=en:vegetarian | rel=r_associated | relid=0 | w=25
  210. en:male population group -- r_associated #0: 25 / 0.926 -> en:veterans
    n1=en:male population group | n2=en:veterans | rel=r_associated | relid=0 | w=25
  211. en:male population group -- r_associated #0: 25 / 0.926 -> en:visitors to patients
    n1=en:male population group | n2=en:visitors to patients | rel=r_associated | relid=0 | w=25
  212. en:male population group -- r_associated #0: 25 / 0.926 -> en:voluntary workers
    n1=en:male population group | n2=en:voluntary workers | rel=r_associated | relid=0 | w=25
  213. en:male population group -- r_associated #0: 25 / 0.926 -> en:vulnerable populations
    n1=en:male population group | n2=en:vulnerable populations | rel=r_associated | relid=0 | w=25
  214. en:male population group -- r_associated #0: 25 / 0.926 -> en:ward
    n1=en:male population group | n2=en:ward | rel=r_associated | relid=0 | w=25
  215. en:male population group -- r_associated #0: 25 / 0.926 -> en:wellness and lifestyle
    n1=en:male population group | n2=en:wellness and lifestyle | rel=r_associated | relid=0 | w=25
  216. en:male population group -- r_associated #0: 25 / 0.926 -> en:woman
    n1=en:male population group | n2=en:woman | rel=r_associated | relid=0 | w=25
  217. en:male population group -- r_associated #0: 25 / 0.926 -> en:working poor
    n1=en:male population group | n2=en:working poor | rel=r_associated | relid=0 | w=25
  218. en:male population group -- r_associated #0: 25 / 0.926 -> en:wounds and injuries
    n1=en:male population group | n2=en:wounds and injuries | rel=r_associated | relid=0 | w=25
  219. en:male population group -- r_associated #0: 25 / 0.926 -> en:xx male
    n1=en:male population group | n2=en:xx male | rel=r_associated | relid=0 | w=25
  220. en:male population group -- r_associated #0: 25 / 0.926 -> en:young adult
    n1=en:male population group | n2=en:young adult | rel=r_associated | relid=0 | w=25
  221. en:male population group -- r_associated #0: 25 / 0.926 -> en:young adult human (21-34)
    n1=en:male population group | n2=en:young adult human (21-34) | rel=r_associated | relid=0 | w=25
  222. en:male population group -- r_associated #0: 25 / 0.926 -> groupe
    n1=en:male population group | n2=groupe | rel=r_associated | relid=0 | w=25
  223. en:male population group -- r_associated #0: 25 / 0.926 -> homme
    n1=en:male population group | n2=homme | rel=r_associated | relid=0 | w=25
  224. en:male population group -- r_associated #0: 25 / 0.926 -> hommes
    n1=en:male population group | n2=hommes | rel=r_associated | relid=0 | w=25
  225. en:male population group -- r_associated #0: 25 / 0.926 -> le sexe fort
    n1=en:male population group | n2=le sexe fort | rel=r_associated | relid=0 | w=25
  226. en:male population group -- r_associated #0: 25 / 0.926 -> sexe fort
    n1=en:male population group | n2=sexe fort | rel=r_associated | relid=0 | w=25
  227. en:male population group -- r_associated #0: 20 / 0.741 -> adolescent, adolescente
    n1=en:male population group | n2=adolescent, adolescente | rel=r_associated | relid=0 | w=20
  228. en:male population group -- r_associated #0: 20 / 0.741 -> adolescente
    n1=en:male population group | n2=adolescente | rel=r_associated | relid=0 | w=20
  229. en:male population group -- r_associated #0: 20 / 0.741 -> adulte d'âge moyen
    n1=en:male population group | n2=adulte d'âge moyen | rel=r_associated | relid=0 | w=20
  230. en:male population group -- r_associated #0: 20 / 0.741 -> adultes d'age moyen
    n1=en:male population group | n2=adultes d'age moyen | rel=r_associated | relid=0 | w=20
  231. en:male population group -- r_associated #0: 20 / 0.741 -> affection du testicule
    n1=en:male population group | n2=affection du testicule | rel=r_associated | relid=0 | w=20
  232. en:male population group -- r_associated #0: 20 / 0.741 -> alcooliques
    n1=en:male population group | n2=alcooliques | rel=r_associated | relid=0 | w=20
  233. en:male population group -- r_associated #0: 20 / 0.741 -> blastome
    n1=en:male population group | n2=blastome | rel=r_associated | relid=0 | w=20
  234. en:male population group -- r_associated #0: 20 / 0.741 -> cancer de la testicule
    n1=en:male population group | n2=cancer de la testicule | rel=r_associated | relid=0 | w=20
  235. en:male population group -- r_associated #0: 20 / 0.741 -> cancer des testicules
    n1=en:male population group | n2=cancer des testicules | rel=r_associated | relid=0 | w=20
  236. en:male population group -- r_associated #0: 20 / 0.741 -> cancer du testicule
    n1=en:male population group | n2=cancer du testicule | rel=r_associated | relid=0 | w=20
  237. en:male population group -- r_associated #0: 20 / 0.741 -> cancer testiculaire
    n1=en:male population group | n2=cancer testiculaire | rel=r_associated | relid=0 | w=20
  238. en:male population group -- r_associated #0: 20 / 0.741 -> cancers
    n1=en:male population group | n2=cancers | rel=r_associated | relid=0 | w=20
  239. en:male population group -- r_associated #0: 20 / 0.741 -> catégorie d'âge
    n1=en:male population group | n2=catégorie d'âge | rel=r_associated | relid=0 | w=20
  240. en:male population group -- r_associated #0: 20 / 0.741 -> circoncision des hommes
    n1=en:male population group | n2=circoncision des hommes | rel=r_associated | relid=0 | w=20
  241. en:male population group -- r_associated #0: 20 / 0.741 -> circoncision masculine
    n1=en:male population group | n2=circoncision masculine | rel=r_associated | relid=0 | w=20
  242. en:male population group -- r_associated #0: 20 / 0.741 -> classe d'âge
    n1=en:male population group | n2=classe d'âge | rel=r_associated | relid=0 | w=20
  243. en:male population group -- r_associated #0: 20 / 0.741 -> consultante
    n1=en:male population group | n2=consultante | rel=r_associated | relid=0 | w=20
  244. en:male population group -- r_associated #0: 20 / 0.741 -> contraception
    n1=en:male population group | n2=contraception | rel=r_associated | relid=0 | w=20
  245. en:male population group -- r_associated #0: 20 / 0.741 -> diabète (accidents vasculaires cérébraux du)
    n1=en:male population group | n2=diabète (accidents vasculaires cérébraux du) | rel=r_associated | relid=0 | w=20
  246. en:male population group -- r_associated #0: 20 / 0.741 -> diabète sucré
    n1=en:male population group | n2=diabète sucré | rel=r_associated | relid=0 | w=20
  247. en:male population group -- r_associated #0: 20 / 0.741 -> diabète sucré de type 2 avec surdité
    n1=en:male population group | n2=diabète sucré de type 2 avec surdité | rel=r_associated | relid=0 | w=20
  248. en:male population group -- r_associated #0: 20 / 0.741 -> diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale
    n1=en:male population group | n2=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | rel=r_associated | relid=0 | w=20
  249. en:male population group -- r_associated #0: 20 / 0.741 -> en:adolescent
    n1=en:male population group | n2=en:adolescent | rel=r_associated | relid=0 | w=20
  250. en:male population group -- r_associated #0: 20 / 0.741 -> en:age bracket
    n1=en:male population group | n2=en:age bracket | rel=r_associated | relid=0 | w=20
  251. en:male population group -- r_associated #0: 20 / 0.741 -> en:age grade
    n1=en:male population group | n2=en:age grade | rel=r_associated | relid=0 | w=20
  252. en:male population group -- r_associated #0: 20 / 0.741 -> en:age-grade
    n1=en:male population group | n2=en:age-grade | rel=r_associated | relid=0 | w=20
  253. en:male population group -- r_associated #0: 20 / 0.741 -> en:age-set
    n1=en:male population group | n2=en:age-set | rel=r_associated | relid=0 | w=20
  254. en:male population group -- r_associated #0: 20 / 0.741 -> en:applicant (person)
    n1=en:male population group | n2=en:applicant (person) | rel=r_associated | relid=0 | w=20
  255. en:male population group -- r_associated #0: 20 / 0.741 -> en:contracting authority
    n1=en:male population group | n2=en:contracting authority | rel=r_associated | relid=0 | w=20
  256. en:male population group -- r_associated #0: 20 / 0.741 -> en:delegate (person)
    n1=en:male population group | n2=en:delegate (person) | rel=r_associated | relid=0 | w=20
  257. en:male population group -- r_associated #0: 20 / 0.741 -> en:disability
    n1=en:male population group | n2=en:disability | rel=r_associated | relid=0 | w=20
  258. en:male population group -- r_associated #0: 20 / 0.741 -> en:epulides
    n1=en:male population group | n2=en:epulides | rel=r_associated | relid=0 | w=20
  259. en:male population group -- r_associated #0: 20 / 0.741 -> en:Klinefelter syndrome
    n1=en:male population group | n2=en:Klinefelter syndrome | rel=r_associated | relid=0 | w=20
  260. en:male population group -- r_associated #0: 20 / 0.741 -> en:little one
    n1=en:male population group | n2=en:little one | rel=r_associated | relid=0 | w=20
  261. en:male population group -- r_associated #0: 20 / 0.741 -> en:male gender, self report
    n1=en:male population group | n2=en:male gender, self report | rel=r_associated | relid=0 | w=20
  262. en:male population group -- r_associated #0: 20 / 0.741 -> en:male, self-reported
    n1=en:male population group | n2=en:male, self-reported | rel=r_associated | relid=0 | w=20
  263. en:male population group -- r_associated #0: 20 / 0.741 -> en:malignant neoplasm of testis
    n1=en:male population group | n2=en:malignant neoplasm of testis | rel=r_associated | relid=0 | w=20
  264. en:male population group -- r_associated #0: 20 / 0.741 -> en:middle aged
    n1=en:male population group | n2=en:middle aged | rel=r_associated | relid=0 | w=20
  265. en:male population group -- r_associated #0: 20 / 0.741 -> en:middle aged adult
    n1=en:male population group | n2=en:middle aged adult | rel=r_associated | relid=0 | w=20
  266. en:male population group -- r_associated #0: 20 / 0.741 -> en:powerlessness
    n1=en:male population group | n2=en:powerlessness | rel=r_associated | relid=0 | w=20
  267. en:male population group -- r_associated #0: 20 / 0.741 -> en:project client
    n1=en:male population group | n2=en:project client | rel=r_associated | relid=0 | w=20
  268. en:male population group -- r_associated #0: 20 / 0.741 -> en:project owner
    n1=en:male population group | n2=en:project owner | rel=r_associated | relid=0 | w=20
  269. en:male population group -- r_associated #0: 20 / 0.741 -> en:project ownership
    n1=en:male population group | n2=en:project ownership | rel=r_associated | relid=0 | w=20
  270. en:male population group -- r_associated #0: 20 / 0.741 -> en:public contracting authority
    n1=en:male population group | n2=en:public contracting authority | rel=r_associated | relid=0 | w=20
  271. en:male population group -- r_associated #0: 20 / 0.741 -> en:renal tubulopathy
    n1=en:male population group | n2=en:renal tubulopathy | rel=r_associated | relid=0 | w=20
  272. en:male population group -- r_associated #0: 20 / 0.741 -> en:sexually transmitted disease
    n1=en:male population group | n2=en:sexually transmitted disease | rel=r_associated | relid=0 | w=20
  273. en:male population group -- r_associated #0: 20 / 0.741 -> en:sexually transmitted diseases
    n1=en:male population group | n2=en:sexually transmitted diseases | rel=r_associated | relid=0 | w=20
  274. en:male population group -- r_associated #0: 20 / 0.741 -> en:sexually transmitted infection
    n1=en:male population group | n2=en:sexually transmitted infection | rel=r_associated | relid=0 | w=20
  275. en:male population group -- r_associated #0: 20 / 0.741 -> en:short man
    n1=en:male population group | n2=en:short man | rel=r_associated | relid=0 | w=20
  276. en:male population group -- r_associated #0: 20 / 0.741 -> en:short person
    n1=en:male population group | n2=en:short person | rel=r_associated | relid=0 | w=20
  277. en:male population group -- r_associated #0: 20 / 0.741 -> en:std
    n1=en:male population group | n2=en:std | rel=r_associated | relid=0 | w=20
  278. en:male population group -- r_associated #0: 20 / 0.741 -> en:STD
    n1=en:male population group | n2=en:STD | rel=r_associated | relid=0 | w=20
  279. en:male population group -- r_associated #0: 20 / 0.741 -> en:STI
    n1=en:male population group | n2=en:STI | rel=r_associated | relid=0 | w=20
  280. en:male population group -- r_associated #0: 20 / 0.741 -> en:sugar diabetes
    n1=en:male population group | n2=en:sugar diabetes | rel=r_associated | relid=0 | w=20
  281. en:male population group -- r_associated #0: 20 / 0.741 -> en:testicular cancer
    n1=en:male population group | n2=en:testicular cancer | rel=r_associated | relid=0 | w=20
  282. en:male population group -- r_associated #0: 20 / 0.741 -> en:uroglycosis
    n1=en:male population group | n2=en:uroglycosis | rel=r_associated | relid=0 | w=20
  283. en:male population group -- r_associated #0: 20 / 0.741 -> en:urophtisis
    n1=en:male population group | n2=en:urophtisis | rel=r_associated | relid=0 | w=20
  284. en:male population group -- r_associated #0: 20 / 0.741 -> en:ward (person)
    n1=en:male population group | n2=en:ward (person) | rel=r_associated | relid=0 | w=20
  285. en:male population group -- r_associated #0: 20 / 0.741 -> épulis
    n1=en:male population group | n2=épulis | rel=r_associated | relid=0 | w=20
  286. en:male population group -- r_associated #0: 20 / 0.741 -> fourchette d'âge
    n1=en:male population group | n2=fourchette d'âge | rel=r_associated | relid=0 | w=20
  287. en:male population group -- r_associated #0: 20 / 0.741 -> groupe d'âge
    n1=en:male population group | n2=groupe d'âge | rel=r_associated | relid=0 | w=20
  288. en:male population group -- r_associated #0: 20 / 0.741 -> impotence
    n1=en:male population group | n2=impotence | rel=r_associated | relid=0 | w=20
  289. en:male population group -- r_associated #0: 20 / 0.741 -> infection sexuellement transmissible
    n1=en:male population group | n2=infection sexuellement transmissible | rel=r_associated | relid=0 | w=20
  290. en:male population group -- r_associated #0: 20 / 0.741 -> IST
    (infection sexuellement transmissible)
    n1=en:male population group | n2=IST
    (infection sexuellement transmissible)
    | rel=r_associated | relid=0 | w=20
  291. en:male population group -- r_associated #0: 20 / 0.741 -> maître d'ouvrage
    n1=en:male population group | n2=maître d'ouvrage | rel=r_associated | relid=0 | w=20
  292. en:male population group -- r_associated #0: 20 / 0.741 -> maître d'ouvrage d'exécution
    n1=en:male population group | n2=maître d'ouvrage d'exécution | rel=r_associated | relid=0 | w=20
  293. en:male population group -- r_associated #0: 20 / 0.741 -> maîtrise d'ouvrage
    n1=en:male population group | n2=maîtrise d'ouvrage | rel=r_associated | relid=0 | w=20
  294. en:male population group -- r_associated #0: 20 / 0.741 -> maîtrise d'ouvrage d'exécution
    n1=en:male population group | n2=maîtrise d'ouvrage d'exécution | rel=r_associated | relid=0 | w=20
  295. en:male population group -- r_associated #0: 20 / 0.741 -> maladie infectieuse sexuellement transmissible
    n1=en:male population group | n2=maladie infectieuse sexuellement transmissible | rel=r_associated | relid=0 | w=20
  296. en:male population group -- r_associated #0: 20 / 0.741 -> maladie infectieuse transmise sexuellement
    n1=en:male population group | n2=maladie infectieuse transmise sexuellement | rel=r_associated | relid=0 | w=20
  297. en:male population group -- r_associated #0: 20 / 0.741 -> maladie néoplasique maligne
    n1=en:male population group | n2=maladie néoplasique maligne | rel=r_associated | relid=0 | w=20
  298. en:male population group -- r_associated #0: 20 / 0.741 -> maladie sexuellement transmissible
    n1=en:male population group | n2=maladie sexuellement transmissible | rel=r_associated | relid=0 | w=20
  299. en:male population group -- r_associated #0: 20 / 0.741 -> Maladie sexuellement transmissible
    n1=en:male population group | n2=Maladie sexuellement transmissible | rel=r_associated | relid=0 | w=20
  300. en:male population group -- r_associated #0: 20 / 0.741 -> maladie transmissible sexuellement
    n1=en:male population group | n2=maladie transmissible sexuellement | rel=r_associated | relid=0 | w=20
  301. en:male population group -- r_associated #0: 20 / 0.741 -> maladie vénérienne
    n1=en:male population group | n2=maladie vénérienne | rel=r_associated | relid=0 | w=20
  302. en:male population group -- r_associated #0: 20 / 0.741 -> maladies sexuellement transmises
    n1=en:male population group | n2=maladies sexuellement transmises | rel=r_associated | relid=0 | w=20
  303. en:male population group -- r_associated #0: 20 / 0.741 -> man
    n1=en:male population group | n2=man | rel=r_associated | relid=0 | w=20
  304. en:male population group -- r_associated #0: 20 / 0.741 -> mans
    n1=en:male population group | n2=mans | rel=r_associated | relid=0 | w=20
  305. en:male population group -- r_associated #0: 20 / 0.741 -> MST
    n1=en:male population group | n2=MST | rel=r_associated | relid=0 | w=20
  306. en:male population group -- r_associated #0: 20 / 0.741 -> MST
    (maladie sexuellement transmissible)
    n1=en:male population group | n2=MST
    (maladie sexuellement transmissible)
    | rel=r_associated | relid=0 | w=20
  307. en:male population group -- r_associated #0: 20 / 0.741 -> mts
    n1=en:male population group | n2=mts | rel=r_associated | relid=0 | w=20
  308. en:male population group -- r_associated #0: 20 / 0.741 -> neo
    n1=en:male population group | n2=neo | rel=r_associated | relid=0 | w=20
  309. en:male population group -- r_associated #0: 20 / 0.741 -> néoplasme malin non classé
    n1=en:male population group | n2=néoplasme malin non classé | rel=r_associated | relid=0 | w=20
  310. en:male population group -- r_associated #0: 20 / 0.741 -> slaves
    n1=en:male population group | n2=slaves | rel=r_associated | relid=0 | w=20
  311. en:male population group -- r_associated #0: 20 / 0.741 -> système endocrine
    n1=en:male population group | n2=système endocrine | rel=r_associated | relid=0 | w=20
  312. en:male population group -- r_associated #0: 20 / 0.741 -> système endocrinien
    n1=en:male population group | n2=système endocrinien | rel=r_associated | relid=0 | w=20
  313. en:male population group -- r_associated #0: 20 / 0.741 -> Système endocrinien
    n1=en:male population group | n2=Système endocrinien | rel=r_associated | relid=0 | w=20
  314. en:male population group -- r_associated #0: 20 / 0.741 -> teen-ager
    n1=en:male population group | n2=teen-ager | rel=r_associated | relid=0 | w=20
  315. en:male population group -- r_associated #0: 20 / 0.741 -> teenager
    n1=en:male population group | n2=teenager | rel=r_associated | relid=0 | w=20
  316. en:male population group -- r_associated #0: 20 / 0.741 -> tranche d'âge
    n1=en:male population group | n2=tranche d'âge | rel=r_associated | relid=0 | w=20
  317. en:male population group -- r_associated #0: 20 / 0.741 -> trouble testiculaire
    n1=en:male population group | n2=trouble testiculaire | rel=r_associated | relid=0 | w=20
  318. en:male population group -- r_associated #0: 20 / 0.741 -> tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial
    n1=en:male population group | n2=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | rel=r_associated | relid=0 | w=20
  319. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne d'un testicule
    n1=en:male population group | n2=tumeur maligne d'un testicule | rel=r_associated | relid=0 | w=20
  320. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne de siège non précisé
    n1=en:male population group | n2=tumeur maligne de siège non précisé | rel=r_associated | relid=0 | w=20
  321. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne de siège primitif inconnu
    n1=en:male population group | n2=tumeur maligne de siège primitif inconnu | rel=r_associated | relid=0 | w=20
  322. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne du testicule
    n1=en:male population group | n2=tumeur maligne du testicule | rel=r_associated | relid=0 | w=20
  323. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne non classée
    n1=en:male population group | n2=tumeur maligne non classée | rel=r_associated | relid=0 | w=20
  324. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne sans précision de site
    n1=en:male population group | n2=tumeur maligne sans précision de site | rel=r_associated | relid=0 | w=20
  325. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur maligne testiculaire
    n1=en:male population group | n2=tumeur maligne testiculaire | rel=r_associated | relid=0 | w=20
  326. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur testiculaire
    n1=en:male population group | n2=tumeur testiculaire | rel=r_associated | relid=0 | w=20
  327. en:male population group -- r_associated #0: 20 / 0.741 -> tumeur testiculaire maligne
    n1=en:male population group | n2=tumeur testiculaire maligne | rel=r_associated | relid=0 | w=20
  328. en:male population group -- r_associated #0: 20 / 0.741 -> usager de drogue
    n1=en:male population group | n2=usager de drogue | rel=r_associated | relid=0 | w=20
≈ 247 relations entrantes

  1. en:malignant neoplasm --- r_associated #0: 358 --> en:male population group
    n1=en:malignant neoplasm | n2=en:male population group | rel=r_associated | relid=0 | w=358
  2. néoplasme malin --- r_associated #0: 358 --> en:male population group
    n1=néoplasme malin | n2=en:male population group | rel=r_associated | relid=0 | w=358
  3. maladie néoplasique maligne --- r_associated #0: 355 --> en:male population group
    n1=maladie néoplasique maligne | n2=en:male population group | rel=r_associated | relid=0 | w=355
  4. tumeur maligne de siège primitif inconnu --- r_associated #0: 340 --> en:male population group
    n1=tumeur maligne de siège primitif inconnu | n2=en:male population group | rel=r_associated | relid=0 | w=340
  5. tumeur maligne sans précision de site --- r_associated #0: 340 --> en:male population group
    n1=tumeur maligne sans précision de site | n2=en:male population group | rel=r_associated | relid=0 | w=340
  6. néoplasme malin non classé --- r_associated #0: 330 --> en:male population group
    n1=néoplasme malin non classé | n2=en:male population group | rel=r_associated | relid=0 | w=330
  7. tumeur maligne non classée --- r_associated #0: 320 --> en:male population group
    n1=tumeur maligne non classée | n2=en:male population group | rel=r_associated | relid=0 | w=320
  8. maladie infectieuse transmise sexuellement --- r_associated #0: 275 --> en:male population group
    n1=maladie infectieuse transmise sexuellement | n2=en:male population group | rel=r_associated | relid=0 | w=275
  9. en:sexually transmitted disorder --- r_associated #0: 267 --> en:male population group
    n1=en:sexually transmitted disorder | n2=en:male population group | rel=r_associated | relid=0 | w=267
  10. infection sexuellement transmissible --- r_associated #0: 266 --> en:male population group
    n1=infection sexuellement transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=266
  11. maladie infectieuse sexuellement transmissible --- r_associated #0: 265 --> en:male population group
    n1=maladie infectieuse sexuellement transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=265
  12. maladie sexuellement transmissible --- r_associated #0: 265 --> en:male population group
    n1=maladie sexuellement transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=265
  13. mts --- r_associated #0: 230 --> en:male population group
    n1=mts | n2=en:male population group | rel=r_associated | relid=0 | w=230
  14. maladie transmissible sexuellement --- r_associated #0: 225 --> en:male population group
    n1=maladie transmissible sexuellement | n2=en:male population group | rel=r_associated | relid=0 | w=225
  15. cancer de la testicule --- r_associated #0: 215 --> en:male population group
    n1=cancer de la testicule | n2=en:male population group | rel=r_associated | relid=0 | w=215
  16. tumeur testiculaire maligne --- r_associated #0: 207 --> en:male population group
    n1=tumeur testiculaire maligne | n2=en:male population group | rel=r_associated | relid=0 | w=207
  17. tumeur maligne testiculaire --- r_associated #0: 206 --> en:male population group
    n1=tumeur maligne testiculaire | n2=en:male population group | rel=r_associated | relid=0 | w=206
  18. cancer testiculaire --- r_associated #0: 205 --> en:male population group
    n1=cancer testiculaire | n2=en:male population group | rel=r_associated | relid=0 | w=205
  19. en:malignant testicular neoplasm --- r_associated #0: 203 --> en:male population group
    n1=en:malignant testicular neoplasm | n2=en:male population group | rel=r_associated | relid=0 | w=203
  20. tumeur maligne d'un testicule --- r_associated #0: 203 --> en:male population group
    n1=tumeur maligne d'un testicule | n2=en:male population group | rel=r_associated | relid=0 | w=203
  21. maladie vénérienne --- r_associated #0: 200 --> en:male population group
    n1=maladie vénérienne | n2=en:male population group | rel=r_associated | relid=0 | w=200
  22. MST
    (maladie sexuellement transmissible)
     --- r_associated #0: 195 --> en:male population group
    n1=MST
    (maladie sexuellement transmissible)
    | n2=en:male population group | rel=r_associated | relid=0 | w=195
  23. en:STD --- r_associated #0: 195 --> en:male population group
    n1=en:STD | n2=en:male population group | rel=r_associated | relid=0 | w=195
  24. en:sexually transmitted disease --- r_associated #0: 195 --> en:male population group
    n1=en:sexually transmitted disease | n2=en:male population group | rel=r_associated | relid=0 | w=195
  25. en:sexually transmitted infection --- r_associated #0: 195 --> en:male population group
    n1=en:sexually transmitted infection | n2=en:male population group | rel=r_associated | relid=0 | w=195
  26. cancer du testicule --- r_associated #0: 190 --> en:male population group
    n1=cancer du testicule | n2=en:male population group | rel=r_associated | relid=0 | w=190
  27. tumeur maligne du testicule --- r_associated #0: 185 --> en:male population group
    n1=tumeur maligne du testicule | n2=en:male population group | rel=r_associated | relid=0 | w=185
  28. en:malignant neoplasm of testis --- r_associated #0: 170 --> en:male population group
    n1=en:malignant neoplasm of testis | n2=en:male population group | rel=r_associated | relid=0 | w=170
  29. groupe d'âge --- r_associated #0: 162 --> en:male population group
    n1=groupe d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=162
  30. classe d'âge --- r_associated #0: 160 --> en:male population group
    n1=classe d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=160
  31. en:age group --- r_associated #0: 160 --> en:male population group
    n1=en:age group | n2=en:male population group | rel=r_associated | relid=0 | w=160
  32. neo --- r_associated #0: 150 --> en:male population group
    n1=neo | n2=en:male population group | rel=r_associated | relid=0 | w=150
  33. cancers --- r_associated #0: 145 --> en:male population group
    n1=cancers | n2=en:male population group | rel=r_associated | relid=0 | w=145
  34. en:STI --- r_associated #0: 110 --> en:male population group
    n1=en:STI | n2=en:male population group | rel=r_associated | relid=0 | w=110
  35. en:adolescent --- r_associated #0: 105 --> en:male population group
    n1=en:adolescent | n2=en:male population group | rel=r_associated | relid=0 | w=105
  36. en:teenager --- r_associated #0: 104 --> en:male population group
    n1=en:teenager | n2=en:male population group | rel=r_associated | relid=0 | w=104
  37. teen-ager --- r_associated #0: 102 --> en:male population group
    n1=teen-ager | n2=en:male population group | rel=r_associated | relid=0 | w=102
  38. circoncision masculine --- r_associated #0: 100 --> en:male population group
    n1=circoncision masculine | n2=en:male population group | rel=r_associated | relid=0 | w=100
  39. en:male circumcision --- r_associated #0: 100 --> en:male population group
    n1=en:male circumcision | n2=en:male population group | rel=r_associated | relid=0 | w=100
  40. en:slaves --- r_associated #0: 100 --> en:male population group
    n1=en:slaves | n2=en:male population group | rel=r_associated | relid=0 | w=100
  41. slaves --- r_associated #0: 99 --> en:male population group
    n1=slaves | n2=en:male population group | rel=r_associated | relid=0 | w=99
  42. circoncision des hommes --- r_associated #0: 97 --> en:male population group
    n1=circoncision des hommes | n2=en:male population group | rel=r_associated | relid=0 | w=97
  43. teenager --- r_associated #0: 97 --> en:male population group
    n1=teenager | n2=en:male population group | rel=r_associated | relid=0 | w=97
  44. tumeur maligne de siège non précisé --- r_associated #0: 95 --> en:male population group
    n1=tumeur maligne de siège non précisé | n2=en:male population group | rel=r_associated | relid=0 | w=95
  45. adolescente --- r_associated #0: 90 --> en:male population group
    n1=adolescente | n2=en:male population group | rel=r_associated | relid=0 | w=90
  46. tranche d'âge --- r_associated #0: 90 --> en:male population group
    n1=tranche d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=90
  47. diabète sucré --- r_associated #0: 75 --> en:male population group
    n1=diabète sucré | n2=en:male population group | rel=r_associated | relid=0 | w=75
  48. en:contraception --- r_associated #0: 75 --> en:male population group
    n1=en:contraception | n2=en:male population group | rel=r_associated | relid=0 | w=75
  49. en:sugar diabetes --- r_associated #0: 75 --> en:male population group
    n1=en:sugar diabetes | n2=en:male population group | rel=r_associated | relid=0 | w=75
  50. en:diabetes mellitus --- r_associated #0: 74 --> en:male population group
    n1=en:diabetes mellitus | n2=en:male population group | rel=r_associated | relid=0 | w=74
  51. contraception --- r_associated #0: 73 --> en:male population group
    n1=contraception | n2=en:male population group | rel=r_associated | relid=0 | w=73
  52. en:middle adult --- r_associated #0: 70 --> en:male population group
    n1=en:middle adult | n2=en:male population group | rel=r_associated | relid=0 | w=70
  53. en:middle aged --- r_associated #0: 66 --> en:male population group
    n1=en:middle aged | n2=en:male population group | rel=r_associated | relid=0 | w=66
  54. adulte d'âge moyen --- r_associated #0: 65 --> en:male population group
    n1=adulte d'âge moyen | n2=en:male population group | rel=r_associated | relid=0 | w=65
  55. en:testicular cancer --- r_associated #0: 65 --> en:male population group
    n1=en:testicular cancer | n2=en:male population group | rel=r_associated | relid=0 | w=65
  56. en:age bracket --- r_associated #0: 62 --> en:male population group
    n1=en:age bracket | n2=en:male population group | rel=r_associated | relid=0 | w=62
  57. en:Klinefelter syndrome --- r_associated #0: 60 --> en:male population group
    n1=en:Klinefelter syndrome | n2=en:male population group | rel=r_associated | relid=0 | w=60
  58. système endocrine --- r_associated #0: 60 --> en:male population group
    n1=système endocrine | n2=en:male population group | rel=r_associated | relid=0 | w=60
  59. en:klinefelter syndrome --- r_associated #0: 57 --> en:male population group
    n1=en:klinefelter syndrome | n2=en:male population group | rel=r_associated | relid=0 | w=57
  60. en:endocrine system --- r_associated #0: 56 --> en:male population group
    n1=en:endocrine system | n2=en:male population group | rel=r_associated | relid=0 | w=56
  61. système endocrinien --- r_associated #0: 56 --> en:male population group
    n1=système endocrinien | n2=en:male population group | rel=r_associated | relid=0 | w=56
  62. MST --- r_associated #0: 55 --> en:male population group
    n1=MST | n2=en:male population group | rel=r_associated | relid=0 | w=55
  63. tumeur testiculaire --- r_associated #0: 55 --> en:male population group
    n1=tumeur testiculaire | n2=en:male population group | rel=r_associated | relid=0 | w=55
  64. Maladie sexuellement transmissible --- r_associated #0: 47 --> en:male population group
    n1=Maladie sexuellement transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=47
  65. en:client --- r_associated #0: 45 --> en:male population group
    n1=en:client | n2=en:male population group | rel=r_associated | relid=0 | w=45
  66. en:project owner --- r_associated #0: 45 --> en:male population group
    n1=en:project owner | n2=en:male population group | rel=r_associated | relid=0 | w=45
  67. maître d'ouvrage --- r_associated #0: 45 --> en:male population group
    n1=maître d'ouvrage | n2=en:male population group | rel=r_associated | relid=0 | w=45
  68. maîtrise d'ouvrage --- r_associated #0: 45 --> en:male population group
    n1=maîtrise d'ouvrage | n2=en:male population group | rel=r_associated | relid=0 | w=45
  69. en:project ownership --- r_associated #0: 44 --> en:male population group
    n1=en:project ownership | n2=en:male population group | rel=r_associated | relid=0 | w=44
  70. en:emigrants and immigrants --- r_associated #0: 43 --> en:male population group
    n1=en:emigrants and immigrants | n2=en:male population group | rel=r_associated | relid=0 | w=43
  71. en:psychology qualifier --- r_associated #0: 43 --> en:male population group
    n1=en:psychology qualifier | n2=en:male population group | rel=r_associated | relid=0 | w=43
  72. en:public contracting authority --- r_associated #0: 43 --> en:male population group
    n1=en:public contracting authority | n2=en:male population group | rel=r_associated | relid=0 | w=43
  73. en:contracting authority --- r_associated #0: 42 --> en:male population group
    n1=en:contracting authority | n2=en:male population group | rel=r_associated | relid=0 | w=42
  74. tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial --- r_associated #0: 42 --> en:male population group
    n1=tubulopathie rénale, diabète sucré, ataxie cérébelleuse secondaire à une duplication de l'ADN mitochondrial | n2=en:male population group | rel=r_associated | relid=0 | w=42
  75. en:project client --- r_associated #0: 41 --> en:male population group
    n1=en:project client | n2=en:male population group | rel=r_associated | relid=0 | w=41
  76. en:renal tubulopathy --- r_associated #0: 41 --> en:male population group
    n1=en:renal tubulopathy | n2=en:male population group | rel=r_associated | relid=0 | w=41
  77. impotence --- r_associated #0: 41 --> en:male population group
    n1=impotence | n2=en:male population group | rel=r_associated | relid=0 | w=41
  78. en:disability --- r_associated #0: 40 --> en:male population group
    n1=en:disability | n2=en:male population group | rel=r_associated | relid=0 | w=40
  79. en:impotence --- r_associated #0: 40 --> en:male population group
    n1=en:impotence | n2=en:male population group | rel=r_associated | relid=0 | w=40
  80. en:prostate carcinoma --- r_associated #0: 40 --> en:male population group
    n1=en:prostate carcinoma | n2=en:male population group | rel=r_associated | relid=0 | w=40
  81. adolescent, adolescente --- r_associated #0: 39 --> en:male population group
    n1=adolescent, adolescente | n2=en:male population group | rel=r_associated | relid=0 | w=39
  82. diabète sucré de type 2 avec surdité --- r_associated #0: 39 --> en:male population group
    n1=diabète sucré de type 2 avec surdité | n2=en:male population group | rel=r_associated | relid=0 | w=39
  83. en:adult 18-65 years old --- r_associated #0: 39 --> en:male population group
    n1=en:adult 18-65 years old | n2=en:male population group | rel=r_associated | relid=0 | w=39
  84. en:female reproductive system --- r_associated #0: 39 --> en:male population group
    n1=en:female reproductive system | n2=en:male population group | rel=r_associated | relid=0 | w=39
  85. maladies vénériennes --- r_associated #0: 37 --> en:male population group
    n1=maladies vénériennes | n2=en:male population group | rel=r_associated | relid=0 | w=37
  86. diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale --- r_associated #0: 36 --> en:male population group
    n1=diabète, photomyoclonies, surdité, néphropathie et dysfonction cérébrale | n2=en:male population group | rel=r_associated | relid=0 | w=36
  87. en:child of impaired parents --- r_associated #0: 36 --> en:male population group
    n1=en:child of impaired parents | n2=en:male population group | rel=r_associated | relid=0 | w=36
  88. en:delegate (person) --- r_associated #0: 36 --> en:male population group
    n1=en:delegate (person) | n2=en:male population group | rel=r_associated | relid=0 | w=36
  89. en:genetic carrier --- r_associated #0: 36 --> en:male population group
    n1=en:genetic carrier | n2=en:male population group | rel=r_associated | relid=0 | w=36
  90. en:sexually transmitted diseases --- r_associated #0: 36 --> en:male population group
    n1=en:sexually transmitted diseases | n2=en:male population group | rel=r_associated | relid=0 | w=36
  91. maladies sexuellement transmissibles --- r_associated #0: 36 --> en:male population group
    n1=maladies sexuellement transmissibles | n2=en:male population group | rel=r_associated | relid=0 | w=36
  92. affection du testicule --- r_associated #0: 35 --> en:male population group
    n1=affection du testicule | n2=en:male population group | rel=r_associated | relid=0 | w=35
  93. alcooliques --- r_associated #0: 35 --> en:male population group
    n1=alcooliques | n2=en:male population group | rel=r_associated | relid=0 | w=35
  94. en:alcoholics --- r_associated #0: 35 --> en:male population group
    n1=en:alcoholics | n2=en:male population group | rel=r_associated | relid=0 | w=35
  95. en:contact person --- r_associated #0: 35 --> en:male population group
    n1=en:contact person | n2=en:male population group | rel=r_associated | relid=0 | w=35
  96. en:infection --- r_associated #0: 35 --> en:male population group
    n1=en:infection | n2=en:male population group | rel=r_associated | relid=0 | w=35
  97. en:kidneys and urinary system --- r_associated #0: 35 --> en:male population group
    n1=en:kidneys and urinary system | n2=en:male population group | rel=r_associated | relid=0 | w=35
  98. en:reader --- r_associated #0: 35 --> en:male population group
    n1=en:reader | n2=en:male population group | rel=r_associated | relid=0 | w=35
  99. en:testicular disorder --- r_associated #0: 35 --> en:male population group
    n1=en:testicular disorder | n2=en:male population group | rel=r_associated | relid=0 | w=35
  100. en:woman --- r_associated #0: 35 --> en:male population group
    n1=en:woman | n2=en:male population group | rel=r_associated | relid=0 | w=35
  101. en:young adult human (21-34) --- r_associated #0: 35 --> en:male population group
    n1=en:young adult human (21-34) | n2=en:male population group | rel=r_associated | relid=0 | w=35
  102. trouble testiculaire --- r_associated #0: 35 --> en:male population group
    n1=trouble testiculaire | n2=en:male population group | rel=r_associated | relid=0 | w=35
  103. en:male breast carcinoma --- r_associated #0: 34 --> en:male population group
    n1=en:male breast carcinoma | n2=en:male population group | rel=r_associated | relid=0 | w=34
  104. en:male reproductive system --- r_associated #0: 34 --> en:male population group
    n1=en:male reproductive system | n2=en:male population group | rel=r_associated | relid=0 | w=34
  105. en:male, self-reported --- r_associated #0: 34 --> en:male population group
    n1=en:male, self-reported | n2=en:male population group | rel=r_associated | relid=0 | w=34
  106. en:middle aged adult --- r_associated #0: 34 --> en:male population group
    n1=en:middle aged adult | n2=en:male population group | rel=r_associated | relid=0 | w=34
  107. en:prostate disorder --- r_associated #0: 34 --> en:male population group
    n1=en:prostate disorder | n2=en:male population group | rel=r_associated | relid=0 | w=34
  108. en:unwanted children --- r_associated #0: 34 --> en:male population group
    n1=en:unwanted children | n2=en:male population group | rel=r_associated | relid=0 | w=34
  109. usager de drogue --- r_associated #0: 34 --> en:male population group
    n1=usager de drogue | n2=en:male population group | rel=r_associated | relid=0 | w=34
  110. mans --- r_associated #0: 33 --> en:male population group
    n1=mans | n2=en:male population group | rel=r_associated | relid=0 | w=33
  111. Système endocrinien --- r_associated #0: 32 --> en:male population group
    n1=Système endocrinien | n2=en:male population group | rel=r_associated | relid=0 | w=32
  112. en:child --- r_associated #0: 32 --> en:male population group
    n1=en:child | n2=en:male population group | rel=r_associated | relid=0 | w=32
  113. en:disabled population --- r_associated #0: 32 --> en:male population group
    n1=en:disabled population | n2=en:male population group | rel=r_associated | relid=0 | w=32
  114. en:human old age (65+) --- r_associated #0: 32 --> en:male population group
    n1=en:human old age (65+) | n2=en:male population group | rel=r_associated | relid=0 | w=32
  115. en:infertility --- r_associated #0: 32 --> en:male population group
    n1=en:infertility | n2=en:male population group | rel=r_associated | relid=0 | w=32
  116. en:mature adult --- r_associated #0: 32 --> en:male population group
    n1=en:mature adult | n2=en:male population group | rel=r_associated | relid=0 | w=32
  117. en:student --- r_associated #0: 32 --> en:male population group
    n1=en:student | n2=en:male population group | rel=r_associated | relid=0 | w=32
  118. en:ward (person) --- r_associated #0: 32 --> en:male population group
    n1=en:ward (person) | n2=en:male population group | rel=r_associated | relid=0 | w=32
  119. catégorie d'âge --- r_associated #0: 31 --> en:male population group
    n1=catégorie d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=31
  120. en:patient --- r_associated #0: 31 --> en:male population group
    n1=en:patient | n2=en:male population group | rel=r_associated | relid=0 | w=31
  121. en:terminally ill --- r_associated #0: 31 --> en:male population group
    n1=en:terminally ill | n2=en:male population group | rel=r_associated | relid=0 | w=31
  122. en:tissue donor --- r_associated #0: 31 --> en:male population group
    n1=en:tissue donor | n2=en:male population group | rel=r_associated | relid=0 | w=31
  123. épulis --- r_associated #0: 31 --> en:male population group
    n1=épulis | n2=en:male population group | rel=r_associated | relid=0 | w=31
  124. IST
    (infection sexuellement transmissible)
     --- r_associated #0: 30 --> en:male population group
    n1=IST
    (infection sexuellement transmissible)
    | n2=en:male population group | rel=r_associated | relid=0 | w=30
  125. adultes d'age moyen --- r_associated #0: 30 --> en:male population group
    n1=adultes d'age moyen | n2=en:male population group | rel=r_associated | relid=0 | w=30
  126. blastome --- r_associated #0: 30 --> en:male population group
    n1=blastome | n2=en:male population group | rel=r_associated | relid=0 | w=30
  127. diabète (accidents vasculaires cérébraux du) --- r_associated #0: 30 --> en:male population group
    n1=diabète (accidents vasculaires cérébraux du) | n2=en:male population group | rel=r_associated | relid=0 | w=30
  128. en:age-grade --- r_associated #0: 30 --> en:male population group
    n1=en:age-grade | n2=en:male population group | rel=r_associated | relid=0 | w=30
  129. en:age-set --- r_associated #0: 30 --> en:male population group
    n1=en:age-set | n2=en:male population group | rel=r_associated | relid=0 | w=30
  130. en:laryngectomee --- r_associated #0: 30 --> en:male population group
    n1=en:laryngectomee | n2=en:male population group | rel=r_associated | relid=0 | w=30
  131. en:man --- r_associated #0: 30 --> en:male population group
    n1=en:man | n2=en:male population group | rel=r_associated | relid=0 | w=30
  132. en:urophtisis --- r_associated #0: 30 --> en:male population group
    n1=en:urophtisis | n2=en:male population group | rel=r_associated | relid=0 | w=30
  133. en:young adult --- r_associated #0: 30 --> en:male population group
    n1=en:young adult | n2=en:male population group | rel=r_associated | relid=0 | w=30
  134. maladies sexuellement transmises --- r_associated #0: 30 --> en:male population group
    n1=maladies sexuellement transmises | n2=en:male population group | rel=r_associated | relid=0 | w=30
  135. man --- r_associated #0: 30 --> en:male population group
    n1=man | n2=en:male population group | rel=r_associated | relid=0 | w=30
  136. maître d'ouvrage d'exécution --- r_associated #0: 30 --> en:male population group
    n1=maître d'ouvrage d'exécution | n2=en:male population group | rel=r_associated | relid=0 | w=30
  137. préadolescente --- r_associated #0: 30 --> en:male population group
    n1=préadolescente | n2=en:male population group | rel=r_associated | relid=0 | w=30
  138. en:nurses, male --- r_associated #0: 29 --> en:male population group
    n1=en:nurses, male | n2=en:male population group | rel=r_associated | relid=0 | w=29
  139. en:obese adult --- r_associated #0: 29 --> en:male population group
    n1=en:obese adult | n2=en:male population group | rel=r_associated | relid=0 | w=29
  140. en:powerlessness --- r_associated #0: 29 --> en:male population group
    n1=en:powerlessness | n2=en:male population group | rel=r_associated | relid=0 | w=29
  141. en:screening for prostate cancer --- r_associated #0: 29 --> en:male population group
    n1=en:screening for prostate cancer | n2=en:male population group | rel=r_associated | relid=0 | w=29
  142. en:sex workers --- r_associated #0: 29 --> en:male population group
    n1=en:sex workers | n2=en:male population group | rel=r_associated | relid=0 | w=29
  143. en:short man --- r_associated #0: 29 --> en:male population group
    n1=en:short man | n2=en:male population group | rel=r_associated | relid=0 | w=29
  144. en:age grade --- r_associated #0: 28 --> en:male population group
    n1=en:age grade | n2=en:male population group | rel=r_associated | relid=0 | w=28
  145. en:criminals --- r_associated #0: 28 --> en:male population group
    n1=en:criminals | n2=en:male population group | rel=r_associated | relid=0 | w=28
  146. en:drug user --- r_associated #0: 28 --> en:male population group
    n1=en:drug user | n2=en:male population group | rel=r_associated | relid=0 | w=28
  147. en:epulides --- r_associated #0: 28 --> en:male population group
    n1=en:epulides | n2=en:male population group | rel=r_associated | relid=0 | w=28
  148. en:male gender, self report --- r_associated #0: 28 --> en:male population group
    n1=en:male gender, self report | n2=en:male population group | rel=r_associated | relid=0 | w=28
  149. en:male phenotype --- r_associated #0: 28 --> en:male population group
    n1=en:male phenotype | n2=en:male population group | rel=r_associated | relid=0 | w=28
  150. en:penile disorder --- r_associated #0: 28 --> en:male population group
    n1=en:penile disorder | n2=en:male population group | rel=r_associated | relid=0 | w=28
  151. en:std --- r_associated #0: 28 --> en:male population group
    n1=en:std | n2=en:male population group | rel=r_associated | relid=0 | w=28
  152. consultante --- r_associated #0: 27 --> en:male population group
    n1=consultante | n2=en:male population group | rel=r_associated | relid=0 | w=27
  153. en:short person --- r_associated #0: 27 --> en:male population group
    n1=en:short person | n2=en:male population group | rel=r_associated | relid=0 | w=27
  154. en:uroglycosis --- r_associated #0: 27 --> en:male population group
    n1=en:uroglycosis | n2=en:male population group | rel=r_associated | relid=0 | w=27
  155. en:voluntary workers --- r_associated #0: 27 --> en:male population group
    n1=en:voluntary workers | n2=en:male population group | rel=r_associated | relid=0 | w=27
  156. fourchette d'âge --- r_associated #0: 27 --> en:male population group
    n1=fourchette d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=27
  157. cancer des testicules --- r_associated #0: 26 --> en:male population group
    n1=cancer des testicules | n2=en:male population group | rel=r_associated | relid=0 | w=26
  158. en:applicant (person) --- r_associated #0: 26 --> en:male population group
    n1=en:applicant (person) | n2=en:male population group | rel=r_associated | relid=0 | w=26
  159. en:human middle age (35-64) --- r_associated #0: 26 --> en:male population group
    n1=en:human middle age (35-64) | n2=en:male population group | rel=r_associated | relid=0 | w=26
  160. en:little one --- r_associated #0: 26 --> en:male population group
    n1=en:little one | n2=en:male population group | rel=r_associated | relid=0 | w=26
  161. en:missionaries --- r_associated #0: 26 --> en:male population group
    n1=en:missionaries | n2=en:male population group | rel=r_associated | relid=0 | w=26
  162. en:symptom --- r_associated #0: 26 --> en:male population group
    n1=en:symptom | n2=en:male population group | rel=r_associated | relid=0 | w=26
  163. maîtrise d'ouvrage d'exécution --- r_associated #0: 26 --> en:male population group
    n1=maîtrise d'ouvrage d'exécution | n2=en:male population group | rel=r_associated | relid=0 | w=26
  164. en:men --- r_associated #0: 25 --> en:male population group
    n1=en:men | n2=en:male population group | rel=r_associated | relid=0 | w=25
  165. en:menfolk --- r_associated #0: 25 --> en:male population group
    n1=en:menfolk | n2=en:male population group | rel=r_associated | relid=0 | w=25
  166. en:people --- r_associated #0: 25 --> en:male population group
    n1=en:people | n2=en:male population group | rel=r_associated | relid=0 | w=25
  167. en:person --- r_associated #0: 25 --> en:male population group
    n1=en:person | n2=en:male population group | rel=r_associated | relid=0 | w=25
  168. en:stronger sex --- r_associated #0: 25 --> en:male population group
    n1=en:stronger sex | n2=en:male population group | rel=r_associated | relid=0 | w=25
  169. en:teenage girl --- r_associated #0: 25 --> en:male population group
    n1=en:teenage girl | n2=en:male population group | rel=r_associated | relid=0 | w=25
  170. en:the stronger sex --- r_associated #0: 25 --> en:male population group
    n1=en:the stronger sex | n2=en:male population group | rel=r_associated | relid=0 | w=25
  171. homme --- r_associated #0: 25 --> en:male population group
    n1=homme | n2=en:male population group | rel=r_associated | relid=0 | w=25
  172. hommes --- r_associated #0: 25 --> en:male population group
    n1=hommes | n2=en:male population group | rel=r_associated | relid=0 | w=25
  173. le sexe fort --- r_associated #0: 25 --> en:male population group
    n1=le sexe fort | n2=en:male population group | rel=r_associated | relid=0 | w=25
  174. maîtrise d?ouvrage --- r_associated #0: 25 --> en:male population group
    n1=maîtrise d?ouvrage | n2=en:male population group | rel=r_associated | relid=0 | w=25
  175. sexe fort --- r_associated #0: 25 --> en:male population group
    n1=sexe fort | n2=en:male population group | rel=r_associated | relid=0 | w=25
  176. en:photomyoclonus --- r_associated #0: 24 --> en:male population group
    n1=en:photomyoclonus | n2=en:male population group | rel=r_associated | relid=0 | w=24
  177. en:short woman --- r_associated #0: 24 --> en:male population group
    n1=en:short woman | n2=en:male population group | rel=r_associated | relid=0 | w=24
  178. invalidité (pension d') --- r_associated #0: 23 --> en:male population group
    n1=invalidité (pension d') | n2=en:male population group | rel=r_associated | relid=0 | w=23
  179. en:and cerebellar ataxia due to duplication of mitochondrial DNA --- r_associated #0: 22 --> en:male population group
    n1=en:and cerebellar ataxia due to duplication of mitochondrial DNA | n2=en:male population group | rel=r_associated | relid=0 | w=22
  180. soignée --- r_associated #0: 22 --> en:male population group
    n1=soignée | n2=en:male population group | rel=r_associated | relid=0 | w=22
  181. en:age set --- r_associated #0: 21 --> en:male population group
    n1=en:age set | n2=en:male population group | rel=r_associated | relid=0 | w=21
  182. en:epulis --- r_associated #0: 21 --> en:male population group
    n1=en:epulis | n2=en:male population group | rel=r_associated | relid=0 | w=21
  183. en:male --- r_associated #0: 20 --> en:male population group
    n1=en:male | n2=en:male population group | rel=r_associated | relid=0 | w=20
  184. Adolescente --- r_associated #0: 15 --> en:male population group
    n1=Adolescente | n2=en:male population group | rel=r_associated | relid=0 | w=15
  185. Alcooliques --- r_associated #0: 15 --> en:male population group
    n1=Alcooliques | n2=en:male population group | rel=r_associated | relid=0 | w=15
  186. Cancer des testicules --- r_associated #0: 15 --> en:male population group
    n1=Cancer des testicules | n2=en:male population group | rel=r_associated | relid=0 | w=15
  187. Cancer du testicule --- r_associated #0: 15 --> en:male population group
    n1=Cancer du testicule | n2=en:male population group | rel=r_associated | relid=0 | w=15
  188. Diabète sucré --- r_associated #0: 15 --> en:male population group
    n1=Diabète sucré | n2=en:male population group | rel=r_associated | relid=0 | w=15
  189. Infection sexuellement transmissible --- r_associated #0: 15 --> en:male population group
    n1=Infection sexuellement transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=15
  190. Maladie Sexuellement Transmissible --- r_associated #0: 15 --> en:male population group
    n1=Maladie Sexuellement Transmissible | n2=en:male population group | rel=r_associated | relid=0 | w=15
  191. men --- r_associated #0: 15 --> en:male population group
    n1=men | n2=en:male population group | rel=r_associated | relid=0 | w=15
  192. Cancers --- r_associated #0: 10 --> en:male population group
    n1=Cancers | n2=en:male population group | rel=r_associated | relid=0 | w=10
  193. Contraception --- r_associated #0: 10 --> en:male population group
    n1=Contraception | n2=en:male population group | rel=r_associated | relid=0 | w=10
  194. IST --- r_associated #0: 10 --> en:male population group
    n1=IST | n2=en:male population group | rel=r_associated | relid=0 | w=10
  195. Maladies sexuellement transmissibles --- r_associated #0: 10 --> en:male population group
    n1=Maladies sexuellement transmissibles | n2=en:male population group | rel=r_associated | relid=0 | w=10
  196. Mans --- r_associated #0: 10 --> en:male population group
    n1=Mans | n2=en:male population group | rel=r_associated | relid=0 | w=10
  197. Maître d'Ouvrage --- r_associated #0: 10 --> en:male population group
    n1=Maître d'Ouvrage | n2=en:male population group | rel=r_associated | relid=0 | w=10
  198. Slaves --- r_associated #0: 10 --> en:male population group
    n1=Slaves | n2=en:male population group | rel=r_associated | relid=0 | w=10
  199. Teenager --- r_associated #0: 10 --> en:male population group
    n1=Teenager | n2=en:male population group | rel=r_associated | relid=0 | w=10
  200. Tranche d'âge --- r_associated #0: 10 --> en:male population group
    n1=Tranche d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=10
  201. analysant --- r_associated #0: 10 --> en:male population group
    n1=analysant | n2=en:male population group | rel=r_associated | relid=0 | w=10
  202. analysante --- r_associated #0: 10 --> en:male population group
    n1=analysante | n2=en:male population group | rel=r_associated | relid=0 | w=10
  203. cachexie maligne --- r_associated #0: 10 --> en:male population group
    n1=cachexie maligne | n2=en:male population group | rel=r_associated | relid=0 | w=10
  204. clients --- r_associated #0: 10 --> en:male population group
    n1=clients | n2=en:male population group | rel=r_associated | relid=0 | w=10
  205. crabes --- r_associated #0: 10 --> en:male population group
    n1=crabes | n2=en:male population group | rel=r_associated | relid=0 | w=10
  206. diabète non-insulinodépendant --- r_associated #0: 10 --> en:male population group
    n1=diabète non-insulinodépendant | n2=en:male population group | rel=r_associated | relid=0 | w=10
  207. diabète phosphaté --- r_associated #0: 10 --> en:male population group
    n1=diabète phosphaté | n2=en:male population group | rel=r_associated | relid=0 | w=10
  208. diabète post-transplantation --- r_associated #0: 10 --> en:male population group
    n1=diabète post-transplantation | n2=en:male population group | rel=r_associated | relid=0 | w=10
  209. diabète rénal --- r_associated #0: 10 --> en:male population group
    n1=diabète rénal | n2=en:male population group | rel=r_associated | relid=0 | w=10
  210. en phase terminale --- r_associated #0: 10 --> en:male population group
    n1=en phase terminale | n2=en:male population group | rel=r_associated | relid=0 | w=10
  211. en:advisor --- r_associated #0: 10 --> en:male population group
    n1=en:advisor | n2=en:male population group | rel=r_associated | relid=0 | w=10
  212. en:and cerebral dysfonction --- r_associated #0: 10 --> en:male population group
    n1=en:and cerebral dysfonction | n2=en:male population group | rel=r_associated | relid=0 | w=10
  213. en:bobby soxer --- r_associated #0: 10 --> en:male population group
    n1=en:bobby soxer | n2=en:male population group | rel=r_associated | relid=0 | w=10
  214. en:bobby-soxer --- r_associated #0: 10 --> en:male population group
    n1=en:bobby-soxer | n2=en:male population group | rel=r_associated | relid=0 | w=10
  215. en:deafness --- r_associated #0: 10 --> en:male population group
    n1=en:deafness | n2=en:male population group | rel=r_associated | relid=0 | w=10
  216. en:diabetic strokes --- r_associated #0: 10 --> en:male population group
    n1=en:diabetic strokes | n2=en:male population group | rel=r_associated | relid=0 | w=10
  217. en:functional disability --- r_associated #0: 10 --> en:male population group
    n1=en:functional disability | n2=en:male population group | rel=r_associated | relid=0 | w=10
  218. en:functional impotence --- r_associated #0: 10 --> en:male population group
    n1=en:functional impotence | n2=en:male population group | rel=r_associated | relid=0 | w=10
  219. en:loss of use --- r_associated #0: 10 --> en:male population group
    n1=en:loss of use | n2=en:male population group | rel=r_associated | relid=0 | w=10
  220. en:nephropathy --- r_associated #0: 10 --> en:male population group
    n1=en:nephropathy | n2=en:male population group | rel=r_associated | relid=0 | w=10
  221. en:type II --- r_associated #0: 10 --> en:male population group
    n1=en:type II | n2=en:male population group | rel=r_associated | relid=0 | w=10
  222. en:with deafness --- r_associated #0: 10 --> en:male population group
    n1=en:with deafness | n2=en:male population group | rel=r_associated | relid=0 | w=10
  223. importation (maladie d') --- r_associated #0: 10 --> en:male population group
    n1=importation (maladie d') | n2=en:male population group | rel=r_associated | relid=0 | w=10
  224. malignité --- r_associated #0: 10 --> en:male population group
    n1=malignité | n2=en:male population group | rel=r_associated | relid=0 | w=10
  225. siège primitif inconnu --- r_associated #0: 10 --> en:male population group
    n1=siège primitif inconnu | n2=en:male population group | rel=r_associated | relid=0 | w=10
  226. Groupe d'âge --- r_associated #0: 5 --> en:male population group
    n1=Groupe d'âge | n2=en:male population group | rel=r_associated | relid=0 | w=5
  227. Maladies vénériennes --- r_associated #0: 5 --> en:male population group
    n1=Maladies vénériennes | n2=en:male population group | rel=r_associated | relid=0 | w=5
  228. Mts --- r_associated #0: 5 --> en:male population group
    n1=Mts | n2=en:male population group | rel=r_associated | relid=0 | w=5
  229. diabète bronzé --- r_associated #0: 5 --> en:male population group
    n1=diabète bronzé | n2=en:male population group | rel=r_associated | relid=0 | w=5
  230. diabète de type 1 --- r_associated #0: 5 --> en:male population group
    n1=diabète de type 1 | n2=en:male population group | rel=r_associated | relid=0 | w=5
  231. diabète de type 2 --- r_associated #0: 5 --> en:male population group
    n1=diabète de type 2 | n2=en:male population group | rel=r_associated | relid=0 | w=5
  232. diabète et psychisme --- r_associated #0: 5 --> en:male population group
    n1=diabète et psychisme | n2=en:male population group | rel=r_associated | relid=0 | w=5
  233. diabète et surdité d'origine mitochondriale --- r_associated #0: 5 --> en:male population group
    n1=diabète et surdité d'origine mitochondriale | n2=en:male population group | rel=r_associated | relid=0 | w=5
  234. diabète gestationnel --- r_associated #0: 5 --> en:male population group
    n1=diabète gestationnel | n2=en:male population group | rel=r_associated | relid=0 | w=5
  235. diabète gras --- r_associated #0: 5 --> en:male population group
    n1=diabète gras | n2=en:male population group | rel=r_associated | relid=0 | w=5
  236. diabète insipide --- r_associated #0: 5 --> en:male population group
    n1=diabète insipide | n2=en:male population group | rel=r_associated | relid=0 | w=5
  237. diabète insipide néphrogénique --- r_associated #0: 5 --> en:male population group
    n1=diabète insipide néphrogénique | n2=en:male population group | rel=r_associated | relid=0 | w=5
  238. diabète insulino-requérant --- r_associated #0: 5 --> en:male population group
    n1=diabète insulino-requérant | n2=en:male population group | rel=r_associated | relid=0 | w=5
  239. diabète insulinodépendant --- r_associated #0: 5 --> en:male population group
    n1=diabète insulinodépendant | n2=en:male population group | rel=r_associated | relid=0 | w=5
  240. diabète lipoatrophique congénital --- r_associated #0: 5 --> en:male population group
    n1=diabète lipoatrophique congénital | n2=en:male population group | rel=r_associated | relid=0 | w=5
  241. diabète sucré et complications rénales --- r_associated #0: 5 --> en:male population group
    n1=diabète sucré et complications rénales | n2=en:male population group | rel=r_associated | relid=0 | w=5
  242. diabètes monogéniques --- r_associated #0: 5 --> en:male population group
    n1=diabètes monogéniques | n2=en:male population group | rel=r_associated | relid=0 | w=5
  243. diabètes sucrés et insipides avec atrophie optique et surdité --- r_associated #0: 5 --> en:male population group
    n1=diabètes sucrés et insipides avec atrophie optique et surdité | n2=en:male population group | rel=r_associated | relid=0 | w=5
  244. diabétide génitale --- r_associated #0: 5 --> en:male population group
    n1=diabétide génitale | n2=en:male population group | rel=r_associated | relid=0 | w=5
  245. en:sick person --- r_associated #0: 5 --> en:male population group
    n1=en:sick person | n2=en:male population group | rel=r_associated | relid=0 | w=5
  246. pré-adolescente --- r_associated #0: 5 --> en:male population group
    n1=pré-adolescente | n2=en:male population group | rel=r_associated | relid=0 | w=5
  247. petite --- r_associated #0: -31 --> en:male population group
    n1=petite | n2=en:male population group | rel=r_associated | relid=0 | w=-31
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr